276 related articles for article (PubMed ID: 34956087)
1. Clinical Characteristics and Long-Term Recombinant Human Growth Hormone Treatment of 18q- Syndrome: A Case Report and Literature Review.
Liu S; Chen M; Yang H; Chen S; Wang L; Duan L; Zhu H; Pan H
Front Endocrinol (Lausanne); 2021; 12():776835. PubMed ID: 34956087
[TBL] [Abstract][Full Text] [Related]
2. Good response to long-term therapy with growth hormone in a patient with 9p trisomy syndrome: A case report and review of the literature.
Canton AP; Nishi MY; Furuya TK; Roela RA; Jorge AA
Am J Med Genet A; 2016 Apr; 170A(4):1046-9. PubMed ID: 26689153
[TBL] [Abstract][Full Text] [Related]
3. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
[TBL] [Abstract][Full Text] [Related]
4. The phenotype and rhGH treatment response of ring Chromosome 15 Syndrome: Case report and literature review.
Chen M; Ke X; Liang H; Gong F; Yang H; Wang L; Duan L; Pan H; Cao D; Zhu H
Mol Genet Genomic Med; 2021 Dec; 9(12):e1842. PubMed ID: 34747577
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the influencing factors of recombinant human growth hormone effect in the children with Turner syndrome].
Li J; Wu W; Liang Y; Luo XP
Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):866-870. PubMed ID: 30392213
[No Abstract] [Full Text] [Related]
6. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone treatment in a patient with deletion of the long arm of chromosome 18: An 8-year observation.
Jackowski T; Petriczko E; Horodnicka-Jozwa A; Biczysko-Mokosa A; Szalecki M; Walczak M
Neuro Endocrinol Lett; 2019 Nov; 40(4):169-174. PubMed ID: 32087092
[TBL] [Abstract][Full Text] [Related]
8. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
Ballerini MG; Braslavsky D; Scaglia PA; Keselman A; Rodríguez ME; Martínez A; Freire AV; Domené HM; Jasper HG; Bergadá I; Ropelato MG
Horm Res Paediatr; 2017; 88(5):354-363. PubMed ID: 28926833
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
Takeda A; Cooper K; Bird A; Baxter L; Frampton GK; Gospodarevskaya E; Welch K; Bryant J
Health Technol Assess; 2010 Sep; 14(42):1-209, iii-iv. PubMed ID: 20849734
[TBL] [Abstract][Full Text] [Related]
10. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
[TBL] [Abstract][Full Text] [Related]
11. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
Esen I; Demirel F; Tepe D; Kara O; Koc N
Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
[TBL] [Abstract][Full Text] [Related]
12. [Establishment and validation of predictive model of short term responses to recombinant human growth hormone treatment in prepubertal short stature children with various growth hormone secretary statuses].
Su Z; Li YH; Ma HM; Chen HS; DU ML; Gu YF
Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):757-62. PubMed ID: 19099881
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of different doses of recombinant human growth hormone in the treatment of short stature in children born small for gestational age].
Qie D; Yang F
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Mar; 18(3):247-53. PubMed ID: 26975824
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and Overall Safety of NutropinAq
Coutant R; Bosch Muñoz J; Dumitrescu CP; Schnabel D; Sert C; Perrot V; Dattani M
Front Endocrinol (Lausanne); 2021; 12():676083. PubMed ID: 34113318
[TBL] [Abstract][Full Text] [Related]
15. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.
Wassenaar MJ; Dekkers OM; Pereira AM; Wit JM; Smit JW; Biermasz NR; Romijn JA
J Clin Endocrinol Metab; 2009 Oct; 94(10):3721-30. PubMed ID: 19584188
[TBL] [Abstract][Full Text] [Related]
16. Growth and Clinical Characteristics of Children with Floating-Harbor Syndrome: Analysis of Current Original Data and a Review of the Literature.
Homma TK; Freire BL; Honjo R; Dauber A; Funari MFA; Lerario AM; Albuquerque EVA; Vasques GA; Bertola DR; Kim CA; Malaquias AC; Jorge AAL
Horm Res Paediatr; 2019; 92(2):115-123. PubMed ID: 31715605
[TBL] [Abstract][Full Text] [Related]
17. Impaired GH secretion in patients with SHOX deficiency and efficacy of recombinant human GH therapy.
Iughetti L; Vannelli S; Street ME; Pirazzoli P; Bertelloni S; Radetti G; Capone L; Stasiowska B; Mazzanti L; Gastaldi R; Maggio MC; Predieri B
Horm Res Paediatr; 2012; 78(5-6):279-87. PubMed ID: 23208451
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.
Hou L; Liang Y; Wu W; Lin HH; Luo XP; Ying YQ
Growth Horm IGF Res; 2020; 53-54():101331. PubMed ID: 32777706
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency.
Scalco RC; Melo SS; Pugliese-Pires PN; Funari MF; Nishi MY; Arnhold IJ; Mendonca BB; Jorge AA
J Clin Endocrinol Metab; 2010 Jan; 95(1):328-32. PubMed ID: 19926713
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG Growth Study.
Rhie YJ; Yoo JH; Choi JH; Chae HW; Kim JH; Chung S; Hwang IT; Shin CH; Kim EY; Kim HS
PLoS One; 2019; 14(5):e0216927. PubMed ID: 31095622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
